IL-13

There is 1 paper on IL-13 in aging research: none in people yet, 1 in animals.

Gene

1 paper studies it1 finding

HGNCNCBI GeneTaxon

See all 1 papers on IL-13

At a glance

The findings reach cells, none yet in people. 1 lab in 1 country.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 3 more
  • Animals1

Effects

1

NAD+ metabolism

upin mouse cells1

1 study
  1. IL-13 activates NAD+ metabolism in mouse cells (via Trem2 binding and the Syk-Sp1-SLC25A51 pathway).

    “interleukin (IL)-13 from senescent macrophages directly bound Trem2, activating the Syk-Sp1-SLC25A51 pathway to enhance mitochondrial nicotinamide adenine dinucleotide (NAD)+ transport”

    Cellsvia Trem2 binding and the Syk-Sp1-SLC25A51 pathway

    Macrophage Trem2 deficiency aggravates aging-induced vascular remodeling by acting as a non-classical receptor of interleukin-13

    Molecular biomedicine

More on NAD+ metabolism

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months